A Factor Analysis Approach for Clustering Patient Reported Outcomes

Abstract

Summary Background In the field of radiation oncology, the use of extensive patient reported outcomes is increasingly common to measure adverse side effects after radiotherapy in cancer patients. Factor analysis has the potential to identify an optimal number of latent factors (i.e., symptom groups). However, the ultimate goal of treatment response modeling is to understand the relationship between treatment variables such as radiation dose and symptom groups resulting from FA. Hence, it is crucial to identify clinically more relevant symptom groups and improved response variables from those symptom groups for a quantitative analysis. Objective The goal of this study is to design a computational method for finding clinically relevant symptom groups from PROs and to test associations between symptom groups and radiation dose. Methods We propose a novel approach where exploratory factor analysis is followed by confirmatory factor analysis to determine the relevant number of symptom groups. We also propose to use a combination of symptoms in a symptom group identified as a new response variable in linear regression analysis to investigate the relationship between the symptom group and dose-volume variables. Results We analyzed patient-reported gastrointestinal symptom profiles from 3 datasets in prostate cancer patients treated with radiotherapy. The final structural model of each dataset was validated using the other two datasets and compared to four other existing FA methods. Our systematic EFA-CFA approach provided clinically more relevant solutions than other methods, resulting in new clinically relevant outcome variables that enabled a quantitative analysis. As a result, statistically significant correlations were found between some dose-volume variables to relevant anatomic structures and symptom groups identified by FA. Conclusion Our proposed method can aid in the process of understanding PROs and provide a basis for improving our understanding of radiation-induced side effects.

Soil and management‐related factors contributing to maize yield gaps in western Kenya

“…This can help show consistent factors causing yield gaps over a larger spatial scale and guide policy interventions to enhance yields. The method has been used in clinical studies to obtain general conclusions on clinical conditions (Oh et al, 2016;Ohshiro & Ueda, 2018), but its use in agricultural studies is still low. Combining different methods to examine factors influencing maize yield gaps can provide complementary findings that are relevant at different spatial scales in smallholder farming systems, improving yield gap studies.…”

Artificial intelligence for understanding concussion: Retrospective cluster analysis on the balance and vestibular diagnostic data of concussion patients

“…FA is a statistical method to investigate the relationship between items in a dataset. By combining explorative and confirmatory FA clinically relevant factors might be identified [67]. However, it is also known that FA is a large-sample procedure; generalizable or replicable results are unlikely if the sample is too small [68].…”

Exploring symptom clusters in mild cognitive impairment and dementia with the NIH Toolbox

“…In symptom clusters research, exploratory factor analysis (EFA) has been a preferred approach for detecting clusters of symptoms that may not be expected based on traditional diagnostic groupings or severity delineations (Harris et al, 2022). Considered one of several "variable-centered approaches" of symptom clusters research (in contrast to other "patient-centered approaches," such as latent profile analysis), EFA allows for statistical understanding of how an array of symptoms can be grouped to reveal the underlying structure of symptoms and how they may be related or caused by shared etiologies (Barsevick, 2016;Harris et al, 2022;Oh et al, 2016;Skerman et al, 2012). In the psychometric and neuropsychological assessment traditions, EFA is often used for identifying "domains" for assessment, for psychometric validation of tests or batteries, or for further interpretation of assessments, such as developing composite scores (Ma et al, 2021;Strauss & Fritsch, 2004).…”